Tetrahydrofuran → 5-[(2-Chloroethyl)pyrazol-1-ylmethyl]-6,7-dichloro-2,3-dimethoxyquinoxaline
反応式
[ClH:1].ClCC[C:5]1[CH:6]=[N:7][NH:8][CH:9]=1.[H-].[Na+].Br[CH2:13][C:14]1[C:23]([Cl:24])=[C:22]([Cl:25])[CH:21]=[C:20]2[C:15]=1[N:16]=[C:17]([O:28][CH3:29])[C:18]([O:26][CH3:27])=[N:19]2.O1[CH2:34][CH2:33]CC1>>[Cl:1][CH2:33][CH2:34][CH:13]([N:8]1[CH:9]=[CH:5][CH:6]=[N:7]1)[C:14]1[C:23]([Cl:24])=[C:22]([Cl:25])[CH:21]=[C:20]2[C:15]=1[N:16]=[C:17]([O:28][CH3:29])[C:18]([O:26][CH3:27])=[N:19]2参加物
反応条件
- 温度
- 10 °C
実験手順
4-(2-Chloroethyl)pyrazole hydrochloride (250 mg, 1.0 mmol) was added to a suspension of sodium hydride (90 mg, 80% oil dispersion, 3.0 mmol) in dry tetrahydrofuran (10 mL) at 0° C. under nitrogen with stirring. Immediately 5-bromomethyl-6,7-dichloro-2,3-dimethoxyquinoxaline (352 mg, 1.0 mmol) was added, and the mixture was allowed to warm to 10° C. over 2 hours. The mixture was partitioned between ethyl acetate (50 mL) and water (50 mL). The organic solution was dried (MgSO4) and concentrated under reduced pressure. Purification by flash chromatography (gradient elution with ethyl acetate/hexane), followed by trituration with methanol gave 5-[(2-chloroethyl)pyrazol-1-ylmethyl]-6,7-dichloro-2,3-dimethoxyquinoxaline (254 mg, 63%), as a white solid.
後処理
- customThe mixture was partitioned between ethyl acetate (50 mL) and water (50 mL)
- dry with materialThe organic solution was dried (MgSO4)
- concentrationconcentrated under reduced pressure
- customPurification
- washby flash chromatography (gradient elution with ethyl acetate/hexane)
出典と根拠
- ORDレコード
- ord-200a6dfd31774c54a0d54b6b058b1f7f
- 出典データセット
- uspto-grants-1998_07
- 特許番号
- US05783572
反応ノート
読み込み中…